Neutrophil infiltration and myocarditis in patients with severe COVID-19: A post-mortem study

Aims To investigate cardiac pathology in critically ill patients with coronavirus disease 2019 (COVID-19) and identify associations between pathological changes and clinical characteristics. Methods The present autopsy cohort study included hearts from 26 deceased patients hospitalized in intensive care units due to COVID-19, and was conducted at four sites in Wuhan, China. Cases were divided into a neutrophil infiltration group and a no-neutrophil group based on the presence or absence of histopathologically identified neutrophilic infiltrates. Results Among the 26 patients, histopathological examination identified active myocarditis in four patients. All patients with myocarditis exhibited extensive accompanying neutrophil infiltration, and all patients without myocarditis did not. The neutrophil infiltration group exhibited significantly higher rates of detection of interleukin-6 (100 vs. 4.6%) and tumor necrosis factor-alpha (100 vs. 31.8%) than the no-neutrophil group (both p < 0.05). On admission, four patients with neutrophil infiltration in myocardium had significantly higher baseline levels of aspartate aminotransferase, D dimer, and high-sensitivity C reactive protein than the other 22 patients (all p < 0.05). During hospitalization, patients with neutrophil infiltration had significantly higher maximum creatine kinase-MB (median 280.0 IU/L vs. 38.7 IU/L, p = 0.04) and higher troponin I (median 1.112 ng/ml vs. 0.220 ng/ml, p = 0.56) than patients without neutrophil infiltration. Conclusion Active myocarditis was frequently associated with neutrophil infiltration in the hearts of deceased patients with severe COVID-19. Patients with neutrophil-infiltrated myocarditis had a series of severely abnormal laboratory test results on admission, and high maximum creatine kinase-MB during hospitalization. The role of neutrophils in severe heart injury and systemic conditions in patients with COVID-19 should be emphasized.

[1]  J. Christie,et al.  COVID-19 Critical Illness: A Data-Driven Review. , 2021, Annual review of medicine.

[2]  A. Finn,et al.  Response by Pellegrini et al to Letter Regarding Article, "Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study". , 2021, Circulation.

[3]  L. Zentilin,et al.  Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study , 2021, Clinical Research in Cardiology.

[4]  M. Salomon,et al.  Neutrophil-epithelial interactions augment infectivity and pro-inflammatory responses to SARS-CoV-2 infection. , 2021, bioRxiv : the preprint server for biology.

[5]  L. Zentilin,et al.  SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study , 2021, Clinical Research in Cardiology.

[6]  Yonggang Ma Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction , 2021, Cells.

[7]  X. Bian,et al.  A cohort autopsy study defines COVID-19 systemic pathogenesis , 2021, Cell Research.

[8]  J. Lord,et al.  Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets , 2021, Frontiers in Immunology.

[9]  G. Bowlin,et al.  Patients with COVID-19: in the dark-NETs of neutrophils , 2021, Cell Death & Differentiation.

[10]  C. Newton-Cheh,et al.  Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19 , 2021, Modern Pathology.

[11]  R. Virmani,et al.  Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis , 2021, Journal of the American College of Cardiology.

[12]  Qianghu Wang,et al.  Implications of cardiac markers in risk-stratification and management for COVID-19 patients , 2020, Critical Care.

[13]  Ji-Hong Liu,et al.  Association of liver abnormalities with in-hospital mortality in patients with COVID-19 , 2020, Journal of Hepatology.

[14]  Andrew J. Layman,et al.  COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart , 2020, Circulation.

[15]  A. Mebazaa,et al.  Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study , 2020, Intensive Care Medicine.

[16]  Yue Dong,et al.  Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review , 2020, Mayo Clinic Proceedings.

[17]  M. Halushka,et al.  Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations , 2020, Cardiovascular Pathology.

[18]  E. Aronica,et al.  Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study , 2020, The Lancet Microbe.

[19]  S. Rizzo,et al.  Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study , 2020, European heart journal.

[20]  P. Delvenne,et al.  Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19 , 2020, The Journal of experimental medicine.

[21]  P. Saldiva,et al.  SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology , 2020, The Journal of experimental medicine.

[22]  M. Hémadi,et al.  Tissue damage from neutrophil-induced oxidative stress in COVID-19 , 2020, Nature Reviews Immunology.

[23]  Yanwei Xing,et al.  Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review , 2020, Critical Care.

[24]  P. Kirchhof,et al.  Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.

[25]  Robert A. Campbell,et al.  Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome , 2020, Blood.

[26]  C. Gazzaruso,et al.  Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19 , 2020, Clinical Rheumatology.

[27]  X. Bian Autopsy of COVID-19 patients in China , 2020, National science review.

[28]  H. Anders,et al.  Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19 , 2020, Cells.

[29]  R. V. Vander Heide,et al.  Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans , 2020, The Lancet Respiratory Medicine.

[30]  C. Gazzaruso,et al.  High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia , 2020, Clinical Rheumatology.

[31]  A. Zangrillo,et al.  Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study , 2020, European Journal of Internal Medicine.

[32]  D. Brodie,et al.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, The Lancet.

[33]  R. Gale,et al.  Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis , 2020, Leukemia.

[34]  K. Mertz,et al.  Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.

[35]  Xiaohu Zheng,et al.  Effective treatment of severe COVID-19 patients with tocilizumab , 2020, Proceedings of the National Academy of Sciences.

[36]  R. Woods,et al.  Neutrophil extracellular traps in COVID-19. , 2020, JCI insight.

[37]  J. M. Crawford,et al.  Targeting potential drivers of COVID-19: Neutrophil extracellular traps , 2020, The Journal of experimental medicine.

[38]  M. Nishimura,et al.  Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations , 2020, The Lancet Respiratory Medicine.

[39]  S. Merler,et al.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.

[40]  Chengliang Zhu,et al.  Analysis of heart injury laboratory parameters in 273 COVID‐19 patients in one hospital in Wuhan, China , 2020, Journal of medical virology.

[41]  Yan Zhao,et al.  The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China , 2020, Clinical Immunology.

[42]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[43]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[44]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[45]  T. Phillips Challenges and recommendations , 2019, Forests and Water.

[46]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[47]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[48]  Stephen H. Bell,et al.  A ?scoping review. , 2018, Sexual health.

[49]  S. Perlman,et al.  Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.

[50]  藤倉雄二,et al.  わが国における成人市中肺炎の原因微生物の変遷(Meta‐analysis and systematic review) , 2017 .

[51]  Y. Lam,et al.  A single centre retrospective cohort study to evaluate the association between implementation of an acute myocardial infarction clinical pathway and clinical outcomes. , 2015, International journal of cardiology.

[52]  Y. Pinto,et al.  Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2014, European heart journal.

[53]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[54]  B. Amulic,et al.  Neutrophil extracellular traps , 2011, Current Biology.

[55]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[56]  H. Aretz Myocarditis: the Dallas criteria. , 1987, Human pathology.